Ten pre term infants, mean gestational age 29.5 wk (range 27.5 to 31 wk), were studied (group I). We used the continuous inuline infusion technique for measuring glomerular filtration rate (GFR). GFR, serum creatinine (Screat), osmolal clearance (Cosm), free H 2 0 clearance (C H20 ) and fractional sodium excretion (FeNa) were measured on day 2,3 and 4. Six preterm infants whose mother did not receive ID served as controls (group II). Serum ID levels measured direct Iv after birth varied from 1.9 ng/ml to 0.1 ng/ml in group I. For~enal function parameters (±SD) see table. GFR S creat Cosm CH 2 0 FeNa ml/min/kg umol/l ml/min/kg ml/min/kg % group I 0,60+0,12 104+24 0,029+0,014 0,008+0,017 4,1+1,9 group II 0,82+0,14 89+20 0,047+0,023 0,039+0,031 2,2+1,2 Percutaneous absorption at various ages in pre term infants was studied by using a transdermal stable isotope-labelled compound of (13C6) benzoic acid (BA) . GC MSwas used to analyze hydrolyzed BA recovered from urine at four 6h intervals after application of 1.8mg to 6 infants(31wk gestational age) and 1 infant(25wk gestational age) on d1 and d21 of life. Respectively, mean BA:urine .creatinine=10.69 and 18.73 on d1;and 1.33 and 1.47 on d21. The 25wk baby was also evaluated on d2,d7 and d14 and=13.25, 7.14 and 4.27,respectively. A kinetic model was designed to evaluate excretion kinetics in these infants. The cumulative % dose appearing in the urine at time t is given by %=100(1+(k4 exp(-k2t) -k2 exp(-k4t»/(k2-k4) ,Where k2 relates to transport across viable epidermis to blood and k4 characterizes elimination rate of chemical from blood to urine. Agreement between model and infant data is reasonable and the model is a credible approximation of the processes involved. The data indicated that percutaneous absorption was enhanced shortly after birth but gradually declined over 3 weeks to that expected of a full term infant. Further, the developed kinetic model may have value in predicting plasma and urine kinetics in preterm infants.
'Ihe use of PJrified amiroacid mixtures in childrenwithinbom errors of metabolism on protein restricted diets has led to a reduction of the intake of I1PSt essential micronutrients.As an integral part of glutathione peroxidase (GSH-Px) , se is considered to te essential: i t should thus te provided in adequate amounts as a biologically active COffip:lurd as to prevent selenium deficiency. We proceeded to suWlement 1 child with lysinuric protein intoleral1CP, born 3.l.8l,whom se intake was 1.6 and 0.7 Uj/day (safe and adequate intake: 10-30 Uj/day)eiilier with yeast-se,either with selenite (2 Uj/kg day)durirg a period of 4 weeks each, at one year interval. Se was measured """,kly wi th atomic absorption spectroscoPi in plasma, RBC, urine, faeces and feeds.Weeklybalanceswere calculated. ()6Il-Px activity was measured with butyl peroxide as substrate.
Dlrirg yeast-se suWlementation,se retention awroximated -198% (25 UJ se/day).Plasma se rose (from 9 to 32 UJ/l) as did GSH-Px activity. 'Ihere was ro charges in se levels (+20 UJ!l,N:50 +12 UJ!l},neither in GSH-Px activity durirg and after the seleni te stUay.Se faeces loss:25% Dlrirg this period the child showed also diarrhea,vomitirg, weight loss. In children on long term protein restricted diets,there is a need for se suwlementation. Se has to te provided under a biologically active form. From this preliminary data we had to conclude that selenite was rot available for metabolic processes. 
